Home-based video assessment of ease of movement for patients with Duchenne: Interviews with physical therapists to select movement tasks.

Autor: Contesse MG; Casimir, Kingston, Massachusetts, USA., Hodges J; Casimir, Kingston, Massachusetts, USA., Staunton H; Roche Products Limited, Welwyn Garden City, UK., Lowes LP; Nationwide Children's Hospital, Columbus, Ohio, USA., Elmankabadi B; FibroGen, San Francisco, California, USA., Elder SJ; Casimir, Kingston, Massachusetts, USA., Ormazabal MG; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Dalle Pazze L; Charley's Fund, New York, New York, USA., Leffler MG; Casimir, Kingston, Massachusetts, USA.

Publikováno v: Physiotherapy research international : the journal for researchers and clinicians in physical therapy [Physiother Res Int] 2023 Jan 30, pp. e1993. Date of Electronic Publication: 2023 Jan 30.

Development of Duchenne Video Assessment scorecards to evaluate ease of movement among those with Duchenne muscular dystrophy.

Autor: Contesse MG; Casimir, Kingston, Massachusetts, United States of America., Lowes LP; Nationwide Children's Hospital, Columbus, Ohio, United States of America., White MK; Quality Metric, Johnston, Rhode Island, United States of America., Dalle Pazze L; Charley's Fund, New York, New York, United States of America., McSherry C; Casimir, Kingston, Massachusetts, United States of America., Alfano LN; Nationwide Children's Hospital, Columbus, Ohio, United States of America., Iammarino M; Nationwide Children's Hospital, Columbus, Ohio, United States of America., Reash N; Casimir, Kingston, Massachusetts, United States of America., Bonarrigo K; Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States of America., Kiefer M; MGH Institute of Health Professions, Boston, Massachusetts, United States of America., Laubscher K; University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States of America., McIntyre M; University of Utah, Salt Lake City, Utah, United States of America., Mockler S; University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States of America., Nelson L; University of Texas Southwestern Medical Center, Dallas, Texas, United States of America., Vogel L; Seattle Children's Hospital, Seattle, Washington, United States of America., Leffler MG; Casimir, Kingston, Massachusetts, United States of America.

Publikováno v: PloS one [PLoS One] 2022 Apr 13; Vol. 17 (4), pp. e0266845. Date of Electronic Publication: 2022 Apr 13 (Print Publication: 2022).

Reliability and construct validity of the Duchenne Video Assessment.

Autor: Contesse MG; Casimir, Plymouth, Massachusetts, USA., Sapp ATL; Casimir, Plymouth, Massachusetts, USA., Apkon SD; Children's Hospital Colorado, Aurora, Colorado, USA., Lowes LP; Nationwide Children's Hospital, Columbus, Ohio, USA., Dalle Pazze L; Charley's Fund, New York, New York, USA., Leffler MG; Casimir, Plymouth, Massachusetts, USA.

Publikováno v: Muscle & nerve [Muscle Nerve] 2021 Aug; Vol. 64 (2), pp. 180-189. Date of Electronic Publication: 2021 Jun 16.

"Of Mice and Measures": A Project to Improve How We Advance Duchenne Muscular Dystrophy Therapies to the Clinic.

Autor: Gordish-Dressman H; Children's National Medical Center, Washington, DC, USA., Willmann R; Biozentrum, University of Basel, Basel, Switzerland., Dalle Pazze L; Charley's Fund, New York, NY, USA., Kreibich A; Charley's Fund, New York, NY, USA., van Putten M; Department of Human Genetics, Leiden University Medical Center, the Netherlands., Heydemann A; Department of Physiology and Biophysics, University of Illinois at Chicago, Chicago, IL, USA., Bogdanik L; The Jackson Laboratory, Bar Harbor, ME, USA., Lutz C; The Jackson Laboratory, Bar Harbor, ME, USA., Davies K; Department of Physiology, University of Oxford, Anatomy and Genetics, Oxford, UK., Demonbreun AR; Center for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Duan D; Department of Molecular Microbiology and Immunology, Department of Neurology, Department of Biomedical Sciences and Department of Bioengineering, University of Missouri, Columbia, MO, USA., Elsey D; Summit Therapeutics, Abingdon, Oxfordshire, UK., Fukada SI; Laboratory of Molecular and Cellular Physiology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan., Girgenrath M; Rare Disease Research Unit, Pfizer, CA, USA., Patrick Gonzalez J; Solid Biosciences, Cambridge, MA, USA., Grounds MD; School of Human Science, the University of Western Australia, Perth, Australia., Nichols A; Catabasis Pharmaceuticals, Cambridge, MA, USA., Partridge T; Children's National Medical Center, Washington, DC, USA., Passini M; Sarepta Therapeutics, Inc. Cambridge, MA, USA., Sanarica F; Department of Pharmacy and Drug Sciences, Unit of Pharmacology, University of Bari 'Aldo Moro', Italy., Schnell FJ; Sarepta Therapeutics, Inc. Cambridge, MA, USA., Wells DJ; Department of Comparative Biomedical Sciences, Royal Veterinary College, London, UK., Yokota T; Department of Medical Genetics, University of Alberta, Canada., Young CS; Department of Neurology, Molecular Biology Institute, Center for Duchenne Muscular Dystrophy at UCLA, University of California, Los Angeles, CA, USA., Zhong Z; Wave Life Sciences, Cambridge, MA, USA., Spurney C; Children's National Medical Center, Washington, DC, USA., Spencer M; Department of Neurology, Molecular Biology Institute, Center for Duchenne Muscular Dystrophy at UCLA, University of California, Los Angeles, CA, USA., De Luca A; Department of Pharmacy and Drug Sciences, Unit of Pharmacology, University of Bari 'Aldo Moro', Italy., Nagaraju K; School of Pharmacy and Pharmaceutical Sciences, Binghamton University, New York, USA., Aartsma-Rus A; Department of Human Genetics, Leiden University Medical Center, the Netherlands.

Publikováno v: Journal of neuromuscular diseases [J Neuromuscul Dis] 2018; Vol. 5 (4), pp. 407-417.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.